Followers | 230 |
Posts | 15196 |
Boards Moderated | 0 |
Alias Born | 03/30/2005 |
Monday, November 23, 2020 2:52:16 PM
his reluctance of updating investors in a timely fashion, or even answering basic investor questions, is a poor pubco quality
He is a master at keeping hope alive. He hooked this sucker.
I think it was a big hit to his ego when the grant failed even though we were tied at the hip to a US government RBL collaborator. Yes, yes, now the data wasn't strong enough is the excuse. Well, we have better info for weeks now, even months depending upon which information one wants to use, to apply for a new grant.
I felt way back when this ceo was a deer in headlights. The nefarious crew on here are only bringing to light this poor ceo quality.
what would make me be quiet? post an update to the website that the IND was submitted. where was the cta submitted? what is the dosing schedule? when are interim results? any of you thinking i am asking for too much are in denial. Just like the company pushing the grant stuff for weeks and weeks via pr, we are now at a precipice. Was the IND actually submitted last week? If the CEO, who is also the IR person, would answer that basic question in writing, i think it would go a long way.
i don't mind being ignored... The IPIX CEO got me used to it
Also there are hundreds of other therapeutics out there for BP to sweep under the rug. Why is IPIX so special?
And for those who think that IPIX had to release the PR last week before the IND was submitted because of the PFE and Moderna vaccines, what about the Regeneron news today? FInd a new excuse... seems to be what Leo is good at attracting. Defending a poor CEO quality. Just being honest.
the above is all IMHO (consider this my safe harbor statement)
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM